Skip to main content
Viennadiplomatique

Life

Health, medicine, wellness, beauty, nutrition, and organic living.

Read FDA to Reassess Ebvallo After Unexpected Rejection

FDA to Reassess Ebvallo After Unexpected Rejection

Following a surprising rejection, the FDA will revisit the treatment for a rare cancer, as the developers of Ebvallo have reached an agreement to tackle the concerns raised.

Editorial Staff May 7
Read Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1 Billion

Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1 Billion

In a significant move within the pharmaceutical industry, Angelini Pharma has announced its acquisition of Catalyst Pharmaceuticals, a company specializing in treatments for rare diseases, for $4.1 billion.

Editorial Staff May 7
Read Understanding Variability in Parkinson's Treatment Response

Understanding Variability in Parkinson's Treatment Response

A recent study utilizing machine learning has revealed previously unrecognized forms of Parkinson's disease, potentially shedding light on the varying effectiveness of treatments among patients.

Editorial Staff May 7